Protease-Activated Receptor-2 Activating Peptide is an agonist of Protease-Activated Receptor-2 (PAR-2).
CAT No: R1636
CAS No:171436-38-7
Synonyms/Alias:SLIGRL-NH2;171436-38-7;H-SER-LEU-ILE-GLY-ARG-LEU-NH2;SL-NH2;CHEMBL238078;Ser-Leu-Ile-Gly-Arg-Leu-NH2;(2S,3S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-N-[2-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]-3-methylpentanamide;Ser-Leu-Ile-Gly-Arg-Leu-amide;Ser-Leu-Ile-Gly-Arg-Leu-NH(2);PAR-2 activation peptide;SLIGRL-NH2?;SLIGRL-NH2 2TFA;seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide;PAR-2 (1-6) amide (mouse, rat) trifluoroacetate salt;BDBM85517;C29H56N10O7;HY-P1308;BDBM50477070;HB2920;AKOS024456619;AKOS040763878;AS-82543;DA-77885;FP109453;SLIGRL (modifications: C-terminal amide);CAS_171436-38-7;CS-0029354;G13181;H-Ser-Leu-Ile-Gly-Arg-Leu-NH2; H-SLIGRL-NH2;PAR-2 (1-6) amide (mouse, rat) trifluoroacetate salt, >=97% (HPLC);(2S,3S)-2-[(2S)-2-[(2S)-2-AMINO-3-HYDROXYPROPANAMIDO]-4-METHYLPENTANAMIDO]-N-({[(1S)-4-CARBAMIMIDAMIDO-1-{[(1S)-1-CARBAMOYL-3-METHYLBUTYL]CARBAMOYL}BUTYL]CARBAMOYL}METHYL)-3-METHYLPENTANAMIDE;
Protease-Activated Receptor-2 Activating Peptide is a synthetic peptide designed to specifically activate the protease-activated receptor-2 (PAR-2), a member of the G protein-coupled receptor (GPCR) family. This receptor is widely expressed in various tissues and plays a pivotal role in diverse physiological and pathological processes, including inflammation, pain perception, and vascular function. The peptide mimics the tethered ligand generated by proteolytic cleavage of PAR-2, making it a valuable tool for directly probing receptor activation without the need for endogenous proteases. Its ability to selectively engage PAR-2 signaling pathways has made it an essential reagent in molecular pharmacology, cell biology, and biomedical research focused on dissecting GPCR-mediated mechanisms.
Receptor Signaling Studies: The activating peptide is extensively used to elucidate PAR-2-mediated intracellular signaling cascades. By serving as a direct agonist, it enables researchers to precisely stimulate the receptor and monitor downstream events such as calcium mobilization, MAPK pathway activation, and changes in gene expression. This approach provides clear mechanistic insights into how PAR-2 influences cellular responses, facilitating the dissection of complex signal transduction networks in both native and recombinant systems.
Inflammation Research: The compound is instrumental in exploring the role of PAR-2 in inflammatory processes. Activation of PAR-2 has been implicated in the regulation of cytokine release, leukocyte recruitment, and barrier function in epithelial and endothelial tissues. By applying the peptide in in vitro and ex vivo models, investigators can mimic protease-driven PAR-2 activation, helping to clarify the receptor's contribution to inflammatory signaling and its potential as a modulator of immune responses.
Pain Mechanism Investigation: Experimental models of nociception frequently utilize the PAR-2 activating peptide to study its involvement in pain perception and sensitization. Activation of PAR-2 on sensory neurons has been linked to the modulation of ion channel activity and neuropeptide release, processes central to the development of hyperalgesia and allodynia. The peptide's specificity allows for controlled activation, supporting research into the molecular basis of pain and the identification of novel targets for analgesic intervention.
Vascular Biology Applications: The peptide serves as a functional probe in vascular biology, where PAR-2 is known to regulate endothelial permeability, vascular tone, and angiogenesis. Researchers employ it to investigate how PAR-2 activation influences endothelial cell behavior, smooth muscle contraction, and the interplay between vascular cells under physiological and stress conditions. Such studies are vital for understanding vascular homeostasis and the pathogenesis of disorders involving abnormal vascular responses.
Drug Discovery and Screening: In pharmacological research, the PAR-2 activating peptide is a key reagent for high-throughput screening of receptor modulators and antagonists. Its use in cell-based assays enables the assessment of candidate compounds for their ability to inhibit or modulate PAR-2-driven signaling events. This application supports the identification and characterization of new chemical entities with potential utility in targeting GPCR-mediated pathways for research and development purposes.
Overall, the Protease-Activated Receptor-2 Activating Peptide stands as a versatile and reliable tool for advancing the understanding of PAR-2 biology across multiple research domains. Its well-defined mechanism of action and specificity for PAR-2 make it indispensable for studies aimed at unraveling receptor function, dissecting cellular signaling, and supporting the development of novel pharmacological strategies.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.